---
category: news
title: "A Medicxi-backed start­up looks to tack­le treat­ment-re­sis­tant blood can­cers, and it's go­ing af­ter AML first"
excerpt: "In the hardest-to-treat blood cancers, resistance to therapy is an existential problem for drug developers looking to permanently stave off tumors. A small biotech is chasing an emerging pathway to stop tumors' ability to resist treatment,"
publishedDateTime: 2021-06-10T11:00:00Z
originalUrl: "https://endpts.com/a-medicxi-backed-startup-looks-to-tackle-treatment-resistant-blood-cancers-and-its-going-after-aml-first/"
webUrl: "https://endpts.com/a-medicxi-backed-startup-looks-to-tackle-treatment-resistant-blood-cancers-and-its-going-after-aml-first/"
type: article
quality: 0
heat: 0
published: false

provider:
  name: ENDPOINTS NEWS
  domain: endpts.com

topics:
  - AI

secured: "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;zgsoq0UyWV/38nn4RUyK5A=="
---

